12 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 12 of 12 clinical reviews.
Enclomiphene citrate is used off-label to raise LH, FSH, and testosterone in men with secondary hypogonadism while preserving sperm production. This article reviews the trial evidence, compares it to clomiphene, and outlines a monitoring framework for clinician discussion.
A guide to enclomiphene citrate for fertility, covering off-label status, evidence quality, dosing, and the monitoring protocols used in practice.
Enclomiphene citrate is sometimes used off-label for gynecomastia. Learn about the evidence, dosing protocols, and how it compares to other SERMs like tamoxifen and raloxifene.
A clinical evidence summary of enclomiphene citrate used off-label for gynecomastia, including mechanism of action, trial data, dosing protocols, and how it compares to clomiphene and tamoxifen.
Can enclomiphene citrate treat gynecomastia? We review the pharmacology, off-label evidence, dosing protocols, risks, and how it compares to tamoxifen and raloxifene for male breast tissue reduction.
Enclomiphene citrate is used off-label for gynecomastia by raising endogenous testosterone and correcting the estrogen-to-androgen ratio. Learn the evidence, dosing protocols, and monitoring requirements.
A clinical review of off-label enclomiphene citrate use in secondary hypogonadism, covering trial data, mechanism, dosing frameworks, side-effect profiles, and how it compares to TRT for men who want to preserve fertility.
Evidence-based guide to off-label enclomiphene citrate use in secondary hypogonadism, including dosing protocols, clinical trial data, and comparison to clomiphene and TRT.
Enclomiphene citrate is used off-label for secondary hypogonadism to raise testosterone while preserving fertility. What the evidence actually shows, what remains unverified, and how monitoring should be structured.
Enclomiphene is off-label but normalizes testosterone in about 75% of men while preserving sperm production, unlike testosterone therapy. See the evidence.
Enclomiphene raises testosterone and LH/FSH and preserves sperm production, but no trial has yet proven it improves live birth rates. See the evidence and tradeoffs.
Enclomiphene is off-label for male hypogonadism, approved only for infertility under IND. Trials show 75-90% reach testosterone above 300 ng/dL.